Valuation: OrganiGram Holdings Inc

Market Cap 184M 131M 114M 106M 97.53M 12.51B 186M 1.25B 488M 6.24B 492M 482M 20.67B P/E 2026 *
10.7x
P/E 2027 * 36.5x
Enterprise Value 184M 131M 114M 106M 97.53M 12.51B 186M 1.25B 488M 6.24B 492M 482M 20.67B EV / Sales 2026 *
0.55x
EV / Sales 2027 * 0.42x
Free-Float
69.74%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 15/01/2026
Director of Finance/CFO - 08/01/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 65 29/03/2018
Director/Board Member 56 17/12/2018
Director/Board Member 70 17/12/2018
Change 5-day change 1-year change 3-year change Capi.($)
+4.72%+2.95% - - 131M
+2.58%-1.97%+29.22%+242.51% 222M
+2.15%+2.15%+1.06%+80.95% 131M
-0.02%+2.12%-30.00%-2.33% 83.87M
+5.13%+5.13%+5.13%-34.92% 79.16M
-2.44%+1.79%-41.93%-49.05% 54.51M
Average +2.02%-0.44%-7.30%+47.43% 114.02M
Weighted average by Cap. +2.49%-1.79%+3.90%+103.01%

Financials

2026 *2027 *
Net sales 336M 239M 207M 193M 178M 22.8B 339M 2.27B 889M 11.37B 898M 878M 37.68B 436M 310M 269M 251M 231M 29.6B 441M 2.95B 1.15B 14.76B 1.17B 1.14B 48.92B
Net income 18.08M 12.84M 11.15M 10.39M 9.56M 1.23B 18.24M 122M 47.78M 611M 48.26M 47.19M 2.03B 4M 2.84M 2.47M 2.3M 2.12M 271M 4.04M 27.05M 10.57M 135M 10.68M 10.44M 448M
Net Debt - -
Logo OrganiGram Holdings Inc
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-